OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cardiovascular Nanomedicine: the Route Ahead
Michele Iafisco, Alessio Alogna, Michele Miragoli, et al.
Nanomedicine (2019) Vol. 14, Iss. 18, pp. 2391-2394
Open Access | Times Cited: 39
Michele Iafisco, Alessio Alogna, Michele Miragoli, et al.
Nanomedicine (2019) Vol. 14, Iss. 18, pp. 2391-2394
Open Access | Times Cited: 39
Showing 1-25 of 39 citing articles:
<p>Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases</p>
Rajasekharreddy Pala, V. T. Anju, Madhu Dyavaiah, et al.
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 3741-3769
Open Access | Times Cited: 150
Rajasekharreddy Pala, V. T. Anju, Madhu Dyavaiah, et al.
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 3741-3769
Open Access | Times Cited: 150
Potential and Therapeutic Roles of Diosmin in Human Diseases
Etimad Huwait, Mohammad Mobashir
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1076-1076
Open Access | Times Cited: 91
Etimad Huwait, Mohammad Mobashir
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1076-1076
Open Access | Times Cited: 91
Nanomedicines for cardiovascular disease
Bryan Ronain Smith, Elazer R. Edelman
Nature Cardiovascular Research (2023) Vol. 2, Iss. 4, pp. 351-367
Open Access | Times Cited: 72
Bryan Ronain Smith, Elazer R. Edelman
Nature Cardiovascular Research (2023) Vol. 2, Iss. 4, pp. 351-367
Open Access | Times Cited: 72
Recent Advances in Aptamers-Based Nanosystems for Diagnosis and Therapy of Cardiovascular Diseases: An Updated Review
Hongqin Yu, Jie Yu, Gang Yao
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 2427-2443
Open Access | Times Cited: 2
Hongqin Yu, Jie Yu, Gang Yao
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 2427-2443
Open Access | Times Cited: 2
Nanotheranostics for the Management of Hepatic Ischemia‐Reperfusion Injury
Yu Guan, Weifeng Yao, Ke Yi, et al.
Small (2021) Vol. 17, Iss. 23
Closed Access | Times Cited: 75
Yu Guan, Weifeng Yao, Ke Yi, et al.
Small (2021) Vol. 17, Iss. 23
Closed Access | Times Cited: 75
Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular Diseases
Nura A. Mohamed, Isra Marei, Sérgio Crovella, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1404-1404
Open Access | Times Cited: 47
Nura A. Mohamed, Isra Marei, Sérgio Crovella, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1404-1404
Open Access | Times Cited: 47
Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases
Fangyu Yang, Jianjiang Xue, Guixue Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 40
Fangyu Yang, Jianjiang Xue, Guixue Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 40
Recent advancements in nanotechnology based drug delivery for the management of cardiovascular disease
Aziz Ullah, Muneeb Ullah, Sung In Lim
Current Problems in Cardiology (2024) Vol. 49, Iss. 4, pp. 102396-102396
Closed Access | Times Cited: 11
Aziz Ullah, Muneeb Ullah, Sung In Lim
Current Problems in Cardiology (2024) Vol. 49, Iss. 4, pp. 102396-102396
Closed Access | Times Cited: 11
Precision Nanotoxicology in Drug Development: Current Trends and Challenges in Safety and Toxicity Implications of Customized Multifunctional Nanocarriers for Drug-Delivery Applications
Anas Ahmad, Mohammad Imran, Nisha Sharma
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2463-2463
Open Access | Times Cited: 38
Anas Ahmad, Mohammad Imran, Nisha Sharma
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2463-2463
Open Access | Times Cited: 38
Nanoparticles: Attractive tools to treat colorectal cancer
Nour K. Younis, Rami Roumieh, Emmanuel P. Bassil, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 1-13
Open Access | Times Cited: 36
Nour K. Younis, Rami Roumieh, Emmanuel P. Bassil, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 1-13
Open Access | Times Cited: 36
Nanobiotechnology approaches for cardiovascular diseases: site-specific targeting of drugs and nanoparticles for atherothrombosis
Haikun Liu, Geoffrey A. Pietersz, Karlheinz Peter, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 34
Haikun Liu, Geoffrey A. Pietersz, Karlheinz Peter, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 34
Emerging trends in nano-based antidiabetic therapeutics: a path to effective diabetes management
Ritika Sharma, Shikha Jyoti Borah, Bhawna Verma, et al.
Materials Advances (2023) Vol. 4, Iss. 15, pp. 3091-3113
Open Access | Times Cited: 22
Ritika Sharma, Shikha Jyoti Borah, Bhawna Verma, et al.
Materials Advances (2023) Vol. 4, Iss. 15, pp. 3091-3113
Open Access | Times Cited: 22
Diagnostic and Therapeutic Aptamers
Vittoria Di Mauro, Francesca Cecilia Lauta, Jessica Modica, et al.
JACC Basic to Translational Science (2023) Vol. 9, Iss. 2, pp. 260-277
Open Access | Times Cited: 19
Vittoria Di Mauro, Francesca Cecilia Lauta, Jessica Modica, et al.
JACC Basic to Translational Science (2023) Vol. 9, Iss. 2, pp. 260-277
Open Access | Times Cited: 19
Pulmonary circulation-mediated heart targeting for the prevention of heart failure by inhalation of intrinsically bioactive nanoparticles
Chao Liu, Liyuan Chen, Yongchang Ma, et al.
Theranostics (2021) Vol. 11, Iss. 17, pp. 8550-8569
Open Access | Times Cited: 34
Chao Liu, Liyuan Chen, Yongchang Ma, et al.
Theranostics (2021) Vol. 11, Iss. 17, pp. 8550-8569
Open Access | Times Cited: 34
Nanoscopy for endosomal escape quantification
Teodora Andrian, Roger Riera, Sílvia Pujals, et al.
Nanoscale Advances (2020) Vol. 3, Iss. 1, pp. 10-23
Open Access | Times Cited: 36
Teodora Andrian, Roger Riera, Sílvia Pujals, et al.
Nanoscale Advances (2020) Vol. 3, Iss. 1, pp. 10-23
Open Access | Times Cited: 36
Advanced Drug Delivery Micro- and Nanosystems for Cardiovascular Diseases
Siavash Iravani, Rajender S. Varma
Molecules (2022) Vol. 27, Iss. 18, pp. 5843-5843
Open Access | Times Cited: 21
Siavash Iravani, Rajender S. Varma
Molecules (2022) Vol. 27, Iss. 18, pp. 5843-5843
Open Access | Times Cited: 21
Advances of nanomedicine in treatment of atherosclerosis and thrombosis
Yu Mao, Jun Ren, Lifang Yang
Environmental Research (2023) Vol. 238, pp. 116637-116637
Closed Access | Times Cited: 11
Yu Mao, Jun Ren, Lifang Yang
Environmental Research (2023) Vol. 238, pp. 116637-116637
Closed Access | Times Cited: 11
Advanced Applications of Nanomaterials in Atherosclerosis Diagnosis and Treatment: Challenges and Future Prospects
Junran Tong, Zhiwen Wang, Jiahui Zhang, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 43, pp. 58072-58099
Closed Access | Times Cited: 4
Junran Tong, Zhiwen Wang, Jiahui Zhang, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 43, pp. 58072-58099
Closed Access | Times Cited: 4
A Novel Approach for In Vitro Testing and Hazard Evaluation of Nanoformulated RyR2-Targeting siRNA Drugs Using Human PBMCs
Valeria Bettinsoli, Gloria Melzi, Angela Maria Antonia Crea, et al.
Life (2025) Vol. 15, Iss. 1, pp. 95-95
Open Access
Valeria Bettinsoli, Gloria Melzi, Angela Maria Antonia Crea, et al.
Life (2025) Vol. 15, Iss. 1, pp. 95-95
Open Access
An Elucidative Review to Analytically Sieve the Viability of Nanomedicine Market
Anaida Kad, Archit Pundir, Shailendra Kumar Arya, et al.
Journal of Pharmaceutical Innovation (2020) Vol. 17, Iss. 1, pp. 249-265
Open Access | Times Cited: 25
Anaida Kad, Archit Pundir, Shailendra Kumar Arya, et al.
Journal of Pharmaceutical Innovation (2020) Vol. 17, Iss. 1, pp. 249-265
Open Access | Times Cited: 25
Gene therapy for cardiac diseases: methods, challenges, and future directions
Luca Grisorio, Rossana Bongianino, Matteo Gianeselli, et al.
Cardiovascular Research (2024)
Closed Access | Times Cited: 3
Luca Grisorio, Rossana Bongianino, Matteo Gianeselli, et al.
Cardiovascular Research (2024)
Closed Access | Times Cited: 3
Advance cardiac nanomedicine by targeting the pathophysiological characteristics of heart failure
Congcong Lin, Huile Gao, Liang Ouyang
Journal of Controlled Release (2021) Vol. 337, pp. 494-504
Closed Access | Times Cited: 20
Congcong Lin, Huile Gao, Liang Ouyang
Journal of Controlled Release (2021) Vol. 337, pp. 494-504
Closed Access | Times Cited: 20
Biomimetic and Bioresponsive Nanotherapies for Inflammatory Vascular Diseases
Guoyu Yang, Jinlin Song, Jianxiang Zhang
Nanomedicine (2020) Vol. 15, Iss. 20, pp. 1917-1921
Closed Access | Times Cited: 20
Guoyu Yang, Jinlin Song, Jianxiang Zhang
Nanomedicine (2020) Vol. 15, Iss. 20, pp. 1917-1921
Closed Access | Times Cited: 20
Polymeric Nanoparticles in Hybrid Catalytic Processing and Drug Delivery System
Ramya Rajan, Kaushik Pal, D Jayadev, et al.
Topics in Catalysis (2022) Vol. 65, Iss. 19-20, pp. 1860-1884
Closed Access | Times Cited: 9
Ramya Rajan, Kaushik Pal, D Jayadev, et al.
Topics in Catalysis (2022) Vol. 65, Iss. 19-20, pp. 1860-1884
Closed Access | Times Cited: 9
Alginate sulfate-nanoparticles loaded with hepatocyte growth factor and insulin-like growth factor-1 improve left ventricular repair in a porcine model of myocardial ischemia reperfusion injury
Ming Wu, Beatriz Pelacho, Piet Claus, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 184, pp. 83-91
Closed Access | Times Cited: 5
Ming Wu, Beatriz Pelacho, Piet Claus, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 184, pp. 83-91
Closed Access | Times Cited: 5
